Susquehanna International Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.96M | Buy |
+222,352
| New | +$6.96M | ﹤0.01% | 993 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7166 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6900 |
|
|
2024
Q3 | – | Sell |
-23,036
| Closed | -$898K | – | 6648 |
|
|
2024
Q2 | $898K | Sell |
23,036
-610
| -3% | -$23.8K | ﹤0.01% | 2708 |
|
|
2024
Q1 | $1.02M | Sell |
23,646
-29,305
| -55% | -$1.26M | ﹤0.01% | 2627 |
|
|
2023
Q4 | $2.44M | Buy |
+52,951
| New | +$2.44M | ﹤0.01% | 1738 |
|
|
2023
Q3 | – | Sell |
-8,131
| Closed | -$313K | – | 6474 |
|
|
2023
Q2 | $313K | Sell |
8,131
-7,438
| -48% | -$286K | ﹤0.01% | 4174 |
|
|
2023
Q1 | $557K | Buy |
+15,569
| New | +$557K | ﹤0.01% | 3665 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6852 |
|
|
2022
Q3 | – | Sell |
-34,389
| Closed | -$1.05M | – | 6986 |
|
|
2022
Q2 | $1.05M | Buy |
34,389
+14,198
| +70% | +$432K | ﹤0.01% | 2408 |
|
|
2022
Q1 | $617K | Buy |
+20,191
| New | +$617K | ﹤0.01% | 3434 |
|
|
2021
Q4 | – | Sell |
-26,279
| Closed | -$402K | – | 6530 |
|
|
2021
Q3 | $402K | Sell |
26,279
-25,702
| -49% | -$393K | ﹤0.01% | 3970 |
|
|
2021
Q2 | $968K | Buy |
51,981
+25,999
| +100% | +$484K | ﹤0.01% | 3022 |
|
|
2021
Q1 | $465K | Buy |
+25,982
| New | +$465K | ﹤0.01% | 3928 |
|
|
2017
Q3 | – | Sell |
-19,277
| Closed | -$61K | – | 4337 |
|
|
2017
Q2 | $61K | Buy |
+19,277
| New | +$61K | ﹤0.01% | 3324 |
|